News

Filter

Current filters:

BayerDiabetes

Global insulin market expanded to $20.8 billion in 2012

17-12-2013

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular…

Asia-PacificBayerChinaDiabetesEli LillyGlobalMarkets & MarketingNovo NordiskSanofi

Eylea filed for EU and US approval in diabetic macular edema

Eylea filed for EU and US approval in diabetic macular edema

07-11-2013

US biotech firm Regeneron Pharmaceuticals says its partner German drug major Bayer has submitted an application…

BayerDiabetesEuropeEyleaNorth AmericaOphthalmicsPharmaceuticalRegeneronRegulation

Approved cancer drug potentially could help treat diabetes, Stanford researchers find

16-09-2013

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular…

afliberceptBayerBiotechnologyDiabetesEyleaOncologyPharmaceuticalRegeneronResearchSanofiZaltrap

Strong Ph II results for Regeneron/Bayer’s VEG Trap-Eye macular edema drug

19-02-2010

USA-based Regeneron Pharmaceuticals and partner Bayer HealthCare of Germany announced that VEGF Trap-Eye…

AspirinBayerBayerDiabetesOphthalmicsPharmaceutical

COMPANY SPOTLIGHT

Menarini

Back to top